Charles River Laboratories International, Inc. · NYSE:CRL
Coleman Glenn received 6,640 Charles River Laboratories International, Inc. shares as an award (Form 4)
Traded May 29, 2026 · Filed Jun 2, 2026
On May 29, 2026, Coleman Glenn (EVP & Chief Financial Officer) received 6,640 Charles River Laboratories International, Inc. shares as an award at US$180.71 for US$1.2M, leaving 27,752 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 6,640 shares
- Price
- US$180.71
- Value
- US$1.2M
- Holding after
- 27,752 shares
- Trading plan
- No
- Role
- EVP & Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Award | 6,640 | US$180.71 | 27,752 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- Coleman Glenn
- Charles River Laboratories International, Inc. shareholders
- Form 4 · Coleman Glenn · Oct 2, 2026
- Form 4 · Coleman Glenn · May 4, 2026
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Girshick Birgit · Aug 20, 2026
- Form 4 · Parisotto Shannon M · Aug 20, 2026